ProKidney Corp. Files 10-Q for Q1 2025
Ticker: PROK · Form: 10-Q · Filed: May 12, 2025 · CIK: 1850270
| Field | Detail |
|---|---|
| Company | Prokidney Corp. (PROK) |
| Form Type | 10-Q |
| Filed Date | May 12, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech
TL;DR
PROK 10-Q filed. Financials updated for Q1 2025.
AI Summary
ProKidney Corp. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Social Capital Suvretta Holdings Corp. III, is focused on biological products. Key financial details and operational information are presented in this filing, which was submitted on May 12, 2025.
Why It Matters
This filing provides investors and stakeholders with an update on ProKidney Corp.'s financial health and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a company in the biological products sector, ProKidney Corp. faces inherent risks related to research, development, regulatory approval, and market adoption.
Key Numbers
- 2836 — SIC Code (Biological Products (No Diagnostic Substances))
Key Players & Entities
- PROKIDNEY CORP. (company) — Filer
- Social Capital Suvretta Holdings Corp. III (company) — Former company name
- 20250331 (date) — Reporting period end date
- 20250512 (date) — Filing date
FAQ
What is ProKidney Corp.'s primary business focus?
ProKidney Corp. is focused on Biological Products (No Diagnostic Substances), as indicated by its SIC code 2836.
When was this 10-Q filing submitted?
This 10-Q filing was submitted on May 12, 2025.
What is the reporting period for this 10-Q?
The reporting period for this 10-Q is the quarter ended March 31, 2025.
Did ProKidney Corp. have a previous name?
Yes, ProKidney Corp. was formerly known as Social Capital Suvretta Holdings Corp. III.
Where is ProKidney Corp. headquartered?
ProKidney Corp.'s business address is located at 2000 Frontis Plaza Blvd., Suite 250, Winston-Salem, NC 27103.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding PROKIDNEY CORP. (PROK).